Validation of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR

Journal of Clinical Microbiology

Volumn 50, Issue 6, 2012, Pages 1856-1859

  McTaggart, Lisa R ^a   Wengenack, Nancy L ^b   Richardson, Susan E ^a,c,d  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL LABORATORY; CONTROLLED STUDY; CONVENTIONAL POLYMERASE CHAIN REACTION; DIAGNOSTIC KIT; FUNGAL DETECTION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; INTERMETHOD COMPARISON; LUNG LAVAGE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

BRONCHOALVEOLAR LAVAGE FLUID; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GREAT BRITAIN; HUMANS; MICROBIOLOGICAL TECHNIQUES; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOLOGY; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECII;

EID: 84862108514     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05880-11     Document Type: Article

References (19)

1. Alanio A, et al. 2011. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin. Microbiol. Infect. 17:1531-1537.
2. Arcenas RC, et al. 2006. A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid. Diagn. Microbiol. Infect. Dis. 54:169-175.
3. Bastien P, Procop GW, Reischl U. 2008. Quantitative real-time PCR is not more sensitive than "conventional" PCR. J. Clin. Microbiol. 46:1897-1900. (Pubitemid 351831816)
4. Bollee G, et al. 2007. Clinical picture of Pneumocystis jirovecii pneumonia in cancer patients. Chest 132:1305-1310. (Pubitemid 47621008)
5. Carmona EM, Limper AH. 2011. Update on the diagnosis and treatment of Pneumocystis pneumonia. Ther. Adv. Respir. Dis. 5:41-59.
6. Cushion MT. 2010. Are members of the fungal genus Pneumocystis (a) commensals; (b) opportunists; (c) pathogens; or (d) all of the above? PLoS Pathog. 6:e1001009.
7. Hauser PM, et al. 2011. Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay. J. Clin. Microbiol. 49: 1872-1878.
8. Huggett JF, et al. 2008. Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients. Thorax 63:154 -159.
9. Jiancheng W, et al. 2009. Screening Pneumocystis carinii pneumonia in non-HIV-infected immunocompromised patients using polymerase chain reaction. Diagn. Microbiol. Infect. Dis. 64:396-401.
10. Jung AC, Paauw DS. 1994. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Arch. Intern. Med. 154:2402-2406. (Pubitemid 24348150)
11. Larsen HH, et al. 2002. Development of a rapid real-time PCR assay for quantitation of Pneumocystis carinii f. sp. carinii. J. Clin. Microbiol. 40: 2989-2993. (Pubitemid 35284973)
12. Pulvirenti J, Herrera P, Venkataraman P, Ahmed N. 2003. Pneumocystis carinii pneumonia in HIV-infected patients in the HAART era. AIDS Patient Care STDs 17:261-265. (Pubitemid 36791293)
13. Robberts FJ, Liebowitz LD, Chalkley LJ. 2007. Polymerase chain reaction detection of Pneumocystis jiroveci: evaluation of 9 assays. Diagn. Microbiol. Infect. Dis. 58:385-392. (Pubitemid 47198402)
14. Roblot F, et al. 2002. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocom-promised HIV-negative patients. Eur. J. Clin. Microbiol. Infect. Dis. 21: 523-531. (Pubitemid 35013591)
15. Seah C, et al. 2012. Comparison of the FXG: RESP (Asp-) real-time PCR assay with direct immunofluorescence and calcofluor white staining for the detection of Pneumocystis jirovecii in respiratory specimens. Med. Mycol. 50:324-327.
16. Sepkowitz KA, Brown AE, Armstrong D. 1995. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk. Arch. Intern. Med. 155:1125-1128.
17. Wakefield AE, et al. 1990. Detection of Pneumocystis carinii with DNA amplification. Lancet 336:451-453. (Pubitemid 20264212)
18. Reference deleted.
19. Wilson JW, et al. 2011. Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity. Diagn. Microbiol. Infect. Dis. 69:145-152.